Wednesday 14 February 2018

Reuters Health Report: February 14, 2018

Click to View in Browser
Wednesday, February 14, 2018
Drug copies ready to take next bite out of Roche's cancer sales
LONDON (Reuters) - European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.
U.S. can sue UnitedHealth in $1 billion Medicare case, judge rules
(Reuters) - A federal judge has ruled the U.S. Justice Department can move forward with a lawsuit claiming UnitedHealth Group Inc wrongly retained more than $1 billion from the government healthcare program Medicare.
Tetraphase's antibiotic fails late-stage study, shares plummet
(Reuters) - Tetraphase Pharmaceuticals Inc said on Tuesday its lead experimental antibiotic to treat serious infections did not meet the main goals in a late-stage study, sending its shares plunging more than 60 percent in after-market trading.
Thailand bets on 'magic pills' to boost declining birth rate
BANGKOK (Reuters) - Thailand has tried cash bonuses and tax incentives to boost the country's birth rate, but on Valentine's Day today it adopted a new approach - handing out vitamin pills.
Merck scraps another late-stage Alzheimer's drug study
NEW YORK (Reuters) - Merck & Co Inc on Tuesday said it will end another late-stage trial of an Alzheimer's drug because it was unlikely to work, adding to the pile-up of failures to find an effective treatment for the mind-wasting disease.
Vigilant adherence to celiac diet linked with lower quality of life
(Reuters Health) - People with celiac disease who are extremely vigilant about not ingesting gluten may perceive that their quality of life is reduced, according to a new study.
Novartis gains U.S. approval for delayed MS drug
ZURICH (Reuters) - Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.
Lactalis failed to report salmonella on a product -government official
PARIS (Reuters) - French dairy group Lactalis, facing a growing scandal over salmonella-tainted baby milk, did not report the bacteria had been found on products in the same factory in 2011, a government official said on Tuesday.
Family history increases breast cancer risk even for older women
(Reuters Health) - Women are more likely to develop breast cancer when a mother or sister had this disease, and the risk associated with family history doesn't appear to diminish with age, a U.S. study suggests.
Amerisource deal may not keep Walgreens competitive: analysts
(Reuters) - Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.
Related Video
Using seawater and crisp packets to cut CO2 emissions
Catalyst makes alcohol and perfume from air
A quick-fix on the day's news delivered when you want it. Register Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today
» » MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2018 Thomson Reuters
Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book.
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter Friend us on Facebook